Artificial intelligence (AI) will fundamentally change medicine and healthcare: Diagnostic patient data, e.g. from ECG, EEG or X-ray images, can be analyzed with the help of machine learning,… read more.
Today installation, updating and support for DrugLog is easy because of cloud-based technology; future developments could include antibiotic measurement in blood according to Mats Högberg, CEO of Pharmacolog… read more.
Moderately ill patients hospitalized with COVID-19 have achieved a better rate of respiratory organ support-free days and survival if treated with therapeutic-dose anticoagulation, researchers reported on August 20,2021… read more.
Women have several choices for long-lasting, reversible contraceptives, but most options for men are either single-use, such as condoms, or difficult to reverse, like vasectomies. Now, in a… read more.
Customers quickly identified new applications for the DrugLog device and this led to the development of two new products – WasteLog and PrepLog. Pharmacolog AB CEO Mats Högberg… read more.
Bristol Myers Squibb announced that the European Commission has granted Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), a first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR)… read more.
Researchers report in a newly published study of vasovagal syncope in younger, otherwise healthy patients, that treatment with oral midodrine significantly decreases fainting spells. Vasovagal syncope is the… read more.
DrugLog is a bench-top device that allows rapid verification of the identity and concentration of a drug in a prepared injection. Originally conceived for quality control of compounded,… read more.
The FDA has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for roxadustat for the treatment of anaemia of chronic kidney disease (CKD), in… read more.
A new adhesive that mimics the sticky substance barnacles use to cling to rocks may offer a better way to treat traumatic injuries. Inspired by the sticky substance… read more.
Genentech/Roche announced that the FDA has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq (atezolizumab) as adjuvant treatment following surgery and platinum-based… read more.
Research from APC Microbiome Ireland (APC) at University College Cork (UCC) published in the leading international scientific journal Nature Aging introduces a novel approach to reverse aspects of aging-related deterioration… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
